Search Results
Filters
Healthcare system readiness for the adoption of advanced therapies: learnings from the introduction of CAR T cell therapies in the UK
Health Economics and Market Access function at Cell and Gene Therapy Catapult · Sep 2021 · External linkClinical adoption day workshop report 2020
CGT Catapult · Feb 2021 · pdfIncreasing Patient Access to Advanced Therapies; the UK Perspective
Ian Hollingsworth · Sep 2020 · pdfDeveloping Flow Cytometry Assays for ATMPs
Ryan McCoy · Sep 2020 · pdfAddressing issues for ATMP logistics
Mark Briggs · Jul 2020 · pdfCell and Gene Therapy Catapult clinical trials database 2019
Cell and Gene Therapy Catapult · Jan 2020 · External linkUK cell and gene therapy industry skills demand report
Cell and Gene Therapy Catapult · Dec 2019 · pdfAddressing the sector skills gap in the advanced therapies industry
Science Industry Partnership · Oct 2019 · External linkATMP manufacturing plan: Retaining and attracting ATMP manufacture
Medicine Manufacturing Industry Partnership · Jun 2019 · pdfCatapult ATTC Newsletter May 2019
Cell and Gene Therapy Catapult · May 2019 · pdfGene Therapies and the NHS
New Statesman · May 2019 · External linkWhat are the potential of cell and gene therapies?
Cell and Gene Therapy Catapult · Jan 2019 · pdfRising to the Challenge – ATMP adoption issues
Fiona Thistlethwaite · Oct 2018 · External linkEstablishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy
Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, Laura Mungapen & Matthew Durdy · Aug 2018 · pdfAnticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK
John Gardner, Andrew Webster & Jacqueline Barry · Jan 2018 · pdfReturned 152 item(s)
